What makes inflammatory breast cancer so aggressive
Molecular Determinants of Inflammatory Breast Cancer
This project looks at how inflammation and cellular stress responses in the breast drive aggressive inflammatory breast cancer and seeks clues that could lead to new treatments for people with IBC.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11187223 on NIH RePORTER |
What this research studies
This research connects population findings (like early pregnancy, not breastfeeding, and high body weight) with lab studies of tumor cells to understand why inflammatory breast cancer (IBC) behaves so aggressively. Scientists are measuring gene activity tied to the cells' adaptive stress response in IBC tumor samples and lab models. They will compare these molecular patterns across different IBC cases and relate them to patient histories and outcomes. The work aims to identify biological processes that could be targeted by future therapies.
Who could benefit from this research
Good fit: People diagnosed with inflammatory breast cancer, especially younger or postpartum patients or those willing to donate tumor tissue or medical data, would be the most relevant participants for related research activities.
Not a fit: Patients with non-inflammatory types of breast cancer or unrelated health conditions are unlikely to receive direct benefits from this specific work in the short term.
Why it matters
Potential benefit: If successful, the project could reveal targets for new treatments that reduce IBC aggressiveness and improve survival.
How similar studies have performed: Related lab and epidemiologic studies suggest inflammation and stress-response pathways matter in cancer, but applying these findings specifically to IBC is still largely experimental.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Devi, Gayathri — Duke University
- Study coordinator: Devi, Gayathri
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.